Skip to main content

AusPAR: Golimumab (rmc)

Australian Public Assessment Report
Device/Product Name
Simponi and Simponi Smartject Injector
Active ingredients
Golimumab (rmc)
AusPAR Date
Published
Submission Number
PM-2012-01202-3-3
Submission Type
Extension of indications, Changes to Product Information
Decision
Approved

Help us improve the Therapeutic Goods Administration site